This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Dec 2;79(12):3370.

doi: 10.1093/jac/dkae372.

Correction to: Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results

No authors listed

PMID: 39387712
DOI: 10.1093/jac/dkae372

Published Erratum

Correction to: Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results

No authors listed. J Antimicrob Chemother. 2024.

. 2024 Dec 2;79(12):3370.

doi: 10.1093/jac/dkae372.

PMID: 39387712
DOI: 10.1093/jac/dkae372

No abstract available

PubMed Disclaimer

Erratum for

Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results.
Serris A, Ferre VM, Le Hingrat Q, Bachelard A, Charpentier C, Exarchopoulos M, Damond F, Phung BC, Landman R, Yazdanpanah Y, Descamps D, Joly V, Peytavin G, Ghosn J. Serris A, et al. J Antimicrob Chemother. 2024 Nov 4;79(11):2932-2938. doi: 10.1093/jac/dkae308. J Antimicrob Chemother. 2024. PMID: 39287977

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems